Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2009

Feb 25, 2009

30339_dirs_2009-02-25_40903525-6b70-4a51-9eb9-165808582497.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24

Reporting Person: WORDEN GEOFFREY F (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-24 Common Stock M 9000 $16.4219 Acquired 20786.25 Direct
2009-02-24 Common Stock M 4500 $13.9925 Acquired 25286.25 Direct
2009-02-24 Common Stock F 1963 $32.09 Disposed 23323.25 Direct
2009-02-24 Common Stock F 4606 Disposed 18717.25 Direct
2009-02-24 Common Stock S 6000 $31.4138 Disposed 12717.25 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-24 Stock Option (Right to Buy) $16.4219 M 9000 Disposed 2009-04-27 Common Stock (9000) Direct
2009-02-24 Stock Option (Right to Buy) $13.9925 M 4500 Disposed 2012-04-30 Common Stock (4500) Direct